Avid Bioservices Inc (CDMO)

[freethemice]

There is this oral presentation next month at the annual American Heart Association meeting.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78993901
There might be something interesting about PS and cardiovascular disease.
Session: AOS.703.02a-Novel Signaling Pathways in the Regulation of Endothelial Function
Presentation: 13186 - Development of Novel, Mechanism-Based Therapies to Prevent the Cardiovascular Complications of the Antiphospholipid Syndrome
Pres Time: Wednesday, Nov 07, 2012, 10:00 AM -10:15 AM
Location: Hall A-8
Specialty: +703. Endothelium, Vascular Tone and Nitric Oxide
Keywords: Endothelial function; Nitric oxide; Cardiovascular therapeutics; Thrombosis; Angiogenesis
Authors: Victoria Ulrich, Philip Shaul, Philip Thorpe, Chieko Mineo, UT Southwestern, Dallas, TX
Disclosures: V. Ulrich, None; P. Shaul, None; P. Thorpe, Peregrine Pharmaceuticals, Inc., Significant,Other Research Support; Peregrine Pharmaceuticals, Inc., Significant,Ownership Interest; Peregrine Pharmaceuticals, Inc., Significant,Consultant/Advisory Board; C. Mineo, None.